Los Angeles Capital Management
TNGX icon

Los Angeles Capital Management’s Tango Therapeutics TNGX Stock Holding History

Los Angeles Capital Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.32M Sell
63,220
-1,023
-2% -$14.2K 0.01% 599
2025
Q4 		$512K Buy
64,243
+47,058
+274% +$405K ﹤0.01% 878
2025
Q3 		$144K Buy
17,185
+6,895
+67% +$46.7K ﹤0.01% 1306
2025
Q2 		$52.7K Sell
10,290
-118,820
-92% -$294K ﹤0.01% 1301
2025
Q1 		$177K Buy
129,110
+58,658
+83% +$144K ﹤0.01% 1038
2024
Q4 		$218K Buy
+70,452
New +$327K ﹤0.01% 1034

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Los Angeles Capital Management's TNGX Position: Q1 2026 in Review

Los Angeles Capital Management reduced its Tango Therapeutics (TNGX) stake by 1.6% in Q1 2026, selling an estimated $14.2K and leaving 63,220 shares worth $1.32M. The position accounts for 0.01% of the portfolio, ranked #599.

Los Angeles Capital Management first reported a position in TNGX in Q4 2024 and has held it in 6 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Los Angeles Capital Management held 63,220 shares of Tango Therapeutics worth $1.32M as of Q1 2026.
  • Los Angeles Capital Management sold 1,023 Tango Therapeutics shares in Q1 2026, an estimated $14.2K.
  • Tango Therapeutics made up 0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #599 holding.
  • Los Angeles Capital Management first reported a position in Tango Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.